Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2013 | 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
Sales | 6,268 | 0 | 6,268 | 6,288 | 0 |
Gross Profit | 6,268 | N/A | 6,268 | 6,288 | N/A |
Operating Expenses | 13,314 | 0 | 11,378 | 12,411 | 0 |
Operating Income | -7,046 | N/A | -5,110 | -6,123 | N/A |
Other Income | 8 | 0 | 13 | 22 | 0 |
Pre-tax Income | -7,038 | 0 | -5,097 | -6,101 | 0 |
Income Tax | 190 | N/A | -452 | -588 | N/A |
Net Income Continuous | -7,228 | N/A | -4,645 | -5,513 | N/A |
Net Income | $-7,228 | $N/A | $-4,645 | $-5,513 | $N/A |
EPS Basic Total Ops | -2.47 | N/A | -0.83 | -2.18 | N/A |
EPS Basic Continuous Ops | -1.98 | N/A | -1.35 | -1.64 | N/A |
EPS Diluted Total Ops | -2.47 | N/A | -0.83 | -2.18 | N/A |
EPS Diluted Continuous Ops | -1.98 | N/A | -1.35 | -1.64 | N/A |
EBITDA(a) | $-6,702 | $N/A | $-4,726 | $-6,123 | $N/A |